Login
Home
Charts
Search
Watchlist
Products

Cosmo First Ltd

COSMOFIRST·NSE
867.20+0.52%Wed, 23 Sept '26

Cosmo First Ltd

COSMOFIRST
NSE
867.20
+0.52%
|Wed, 23 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
2,262Cr
Close
Close Price
861.85
Industry
Industry
Packaging - BOPP
PE
Price To Earnings
13.38
PS
Price To Sales
0.56
Revenue
Revenue
4,004Cr
Rev Gr TTM
Revenue Growth TTM
33.23%
PAT Gr TTM
PAT Growth TTM
14.85%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
6646256416907597017468009198991,0211,166
Growth YoY
Revenue Growth YoY%
-14.7-14.4-10.34.914.412.116.316.021.128.336.945.7
Expenses
ExpensesCr
6025825976226726386767088168319001,030
Operating Profit
Operating ProfitCr
614244688763709210368121136
OPM
OPM%
9.36.86.99.811.59.09.411.511.27.611.811.7
Other Income
Other IncomeCr
111423172023152425351011
Interest Expense
Interest ExpenseCr
222326232525273237373638
Depreciation
DepreciationCr
222324242425263034353738
PBT
PBTCr
291018375736335457315871
Tax
TaxCr
7-1261175121122117
PAT
PATCr
221115314630274347303754
Growth YoY
PAT Growth YoY%
-70.6-75.1-51.7122.7112.3160.276.238.52.0-0.236.225.4
NPM
NPM%
3.31.82.44.56.04.23.65.45.13.33.64.6
EPS
EPS
8.34.45.911.917.611.410.516.618.111.414.220.7
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
6646256416907597017468009198991,0211,166
Growth YoY
Revenue Growth YoY%
-14.7-14.4-10.34.914.412.116.316.021.128.336.945.7
Expenses
ExpensesCr
6025825976226726386767088168319001,030
Operating Profit
Operating ProfitCr
614244688763709210368121136
OPM
OPM%
9.36.86.99.811.59.09.411.511.27.611.811.7
Other Income
Other IncomeCr
111423172023152425351011
Interest Expense
Interest ExpenseCr
222326232525273237373638
Depreciation
DepreciationCr
222324242425263034353738
PBT
PBTCr
291018375736335457315871
Tax
TaxCr
7-1261175121122117
PAT
PATCr
221115314630274347303754
Growth YoY
PAT Growth YoY%
-70.6-75.1-51.7122.7112.3160.276.238.52.0-0.236.225.4
NPM
NPM%
3.31.82.44.56.04.23.65.45.13.33.64.6
EPS
EPS
8.34.45.911.917.611.410.516.618.111.414.220.7

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,6211,5871,8472,1572,2042,2853,0383,0652,5872,8953,6394,004
Growth
Revenue Growth%
-1.6-2.116.416.82.23.733.00.9-15.611.925.733.2
Expenses
ExpensesCr
1,4291,4331,7131,9951,9431,8932,4672,6832,4042,6073,2553,577
Operating Profit
Operating ProfitCr
191154133161261392571382183288384428
OPM
OPM%
11.89.77.27.511.817.118.812.57.19.910.510.7
Other Income
Other IncomeCr
-11535201938485268749582
Interest Expense
Interest ExpenseCr
303652565342405589100141148
Depreciation
DepreciationCr
364251546559637589100137145
PBT
PBTCr
12491647216332951730472163201217
Tax
TaxCr
28501149921206010304550
PAT
PATCr
9686646111323739724462133156167
Growth
PAT Growth%
247.9-10.9-24.9-5.285.6108.867.4-38.5-74.5114.516.914.8
NPM
NPM%
5.95.43.52.85.210.413.18.02.44.64.34.2
EPS
EPS
33.029.822.421.339.584.798.590.924.051.560.364.4
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,6211,5871,8472,1572,2042,2853,0383,0652,5872,8953,6394,004
Growth
Revenue Growth%
-1.6-2.116.416.82.23.733.00.9-15.611.925.733.2
Expenses
ExpensesCr
1,4291,4331,7131,9951,9431,8932,4672,6832,4042,6073,2553,577
Operating Profit
Operating ProfitCr
191154133161261392571382183288384428
OPM
OPM%
11.89.77.27.511.817.118.812.57.19.910.510.7
Other Income
Other IncomeCr
-11535201938485268749582
Interest Expense
Interest ExpenseCr
303652565342405589100141148
Depreciation
DepreciationCr
364251546559637589100137145
PBT
PBTCr
12491647216332951730472163201217
Tax
TaxCr
28501149921206010304550
PAT
PATCr
9686646111323739724462133156167
Growth
PAT Growth%
247.9-10.9-24.9-5.285.6108.867.4-38.5-74.5114.516.914.8
NPM
NPM%
5.95.43.52.85.210.413.18.02.44.64.34.2
EPS
EPS
33.029.822.421.339.584.798.590.924.051.560.364.4

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1919191919181826262626
Reserves
ReservesCr
4375546006697218361,1731,2721,3211,4401,590
Current Liabilities
Current LiabilitiesCr
3845016356576907668591,0031,1631,2471,543
Non Current Liabilities
Non Current LiabilitiesCr
3244725115364795057108271,0171,4121,535
Total Liabilities
Total LiabilitiesCr
1,1641,5451,7661,8731,9102,1252,7603,1283,5284,1254,695
Current Assets
Current AssetsCr
3685136607427879941,3731,3291,3821,5581,892
Non Current Assets
Non Current AssetsCr
7951,0331,1051,1311,1231,1311,3871,7992,1462,5672,803
Total Assets
Total AssetsCr
1,1641,5451,7661,8731,9102,1252,7603,1283,5284,1254,695
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1919191919181826262626
Reserves
ReservesCr
4375546006697218361,1731,2721,3211,4401,590
Current Liabilities
Current LiabilitiesCr
3845016356576907668591,0031,1631,2471,543
Non Current Liabilities
Non Current LiabilitiesCr
3244725115364795057108271,0171,4121,535
Total Liabilities
Total LiabilitiesCr
1,1641,5451,7661,8731,9102,1252,7603,1283,5284,1254,695
Current Assets
Current AssetsCr
3685136607427879941,3731,3291,3821,5581,892
Non Current Assets
Non Current AssetsCr
7951,0331,1051,1311,1231,1311,3871,7992,1462,5672,803
Total Assets
Total AssetsCr
1,1641,5451,7661,8731,9102,1252,7603,1283,5284,1254,695

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
2235082143240335481465245166397
Investing Cash Flow
Investing Cash FlowCr
-80-223-123-90-106-105-447-325-235-420-361
Financing Cash Flow
Financing Cash FlowCr
-13816562-35-165-193-52-153-19247-3
Net Cash Flow
Net Cash FlowCr
6-72117-3137-18-13-8-633
Free Cash Flow
Free Cash FlowCr
138-172128719026219985-49-325-8
CFO To PAT
CFO To PAT%
231.758.8127.8233.8211.9141.6121.3190.7394.3124.7254.3
CFO To EBITDA
CFO To EBITDA%
116.632.861.988.692.185.684.2121.7133.857.8103.4
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
2235082143240335481465245166397
Investing Cash Flow
Investing Cash FlowCr
-80-223-123-90-106-105-447-325-235-420-361
Financing Cash Flow
Financing Cash FlowCr
-13816562-35-165-193-52-153-19247-3
Net Cash Flow
Net Cash FlowCr
6-72117-3137-18-13-8-633
Free Cash Flow
Free Cash FlowCr
138-172128719026219985-49-325-8
CFO To PAT
CFO To PAT%
231.758.8127.8233.8211.9141.6121.3190.7394.3124.7254.3
CFO To EBITDA
CFO To EBITDA%
116.632.861.988.692.185.684.2121.7133.857.8103.4

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5667254803774051,1273,1481,5441,3111,6191,5672,262
Price To Earnings
Price To Earnings
6.18.57.56.23.64.87.96.321.112.110.113.4
Price To Sales
Price To Sales
0.30.50.30.20.20.51.00.50.50.60.40.6
Price To Book
Price To Book
1.21.30.80.60.61.32.61.21.01.11.01.4
EV To EBITDA
EV To EBITDA
4.68.28.46.23.94.66.86.312.710.58.39.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
25.925.617.316.822.928.428.922.820.022.923.623.6
OPM
OPM%
11.89.77.27.511.817.118.812.57.19.910.510.7
NPM
NPM%
5.95.43.52.85.210.413.18.02.44.64.34.2
ROCE
ROCE%
19.311.28.99.215.422.927.716.16.89.010.410.4
ROE
ROE%
21.115.010.48.915.327.733.318.84.69.19.79.7
ROA
ROA%
8.35.53.63.35.911.214.47.81.83.23.33.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5667254803774051,1273,1481,5441,3111,6191,5672,262
Price To Earnings
Price To Earnings
6.18.57.56.23.64.87.96.321.112.110.113.4
Price To Sales
Price To Sales
0.30.50.30.20.20.51.00.50.50.60.40.6
Price To Book
Price To Book
1.21.30.80.60.61.32.61.21.01.11.01.4
EV To EBITDA
EV To EBITDA
4.68.28.46.23.94.66.86.312.710.58.39.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
25.925.617.316.822.928.428.922.820.022.923.623.6
OPM
OPM%
11.89.77.27.511.817.118.812.57.19.910.510.7
NPM
NPM%
5.95.43.52.85.210.413.18.02.44.64.34.2
ROCE
ROCE%
19.311.28.99.215.422.927.716.16.89.010.410.4
ROE
ROE%
21.115.010.48.915.327.733.318.84.69.19.79.7
ROA
ROA%
8.35.53.63.35.911.214.47.81.83.23.33.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Cosmo First began in 1981 as the company that introduced BOPP (biaxially oriented polypropylene) films to India - a single-line operation with just 800 tonnes of capacity - and has since evolved into a multinational group whose recurring approach is to enter a market first with an innovation, then systematically move up the value chain from commodity to specialty, using the cash flows of one engine to build the next. Today it is a diversified manufacturing and consumer company with five distinct verticals spanning packaging films, specialty chemicals, rigid packaging, consumer films, and digital-first petcare, all anchored by a central R&D lab with over 30 scientists and a philosophy of providing “industry-first niche solutions”. That de-commoditised model - replacing plain-vanilla products with higher-margin specialties wherever possible - is the thread that runs through every business the group has built. # Business segments Five engines at different stages - a hydrocarbon cash cow, two consumer platforms at national scale, and a green-energy bet under construction - each built with the cash flows of the one before. ## 1. Cosmo Films: the specialty-flexible-packaging engine that funds everything else **The world’s largest supplier of thermal lamination and industrial-application films, earning margins on specialty grades that are roughly three times those on commodity films - and those margins stay intact even when raw-material prices swing.** - **Three margin tiers, only one exposed to commodity cycles** - the business sorts every tonne sold into core films (₹20/kg), semi-specialty (₹36/kg), or specialty (₹63/kg); specialty realisations move with raw-material costs on a pass-through basis, so the absolute margin per kilo is protected, while commodity-film margins rise and fall with market supply and demand. - **World’s largest in three categories** - it is the largest global supplier of thermal lamination films, the largest supplier of industrial-application films, and the second-largest player in specialty label films, serving blue-chip brands such as Unilever, Nestlé, Pepsi, and Amcor across more than 80 countries. - **New lines cut production cost by up to ₹15 a kilo** - the commissioning of a 10.4-metre, 5-layer BOPP line at Waluj (one of the highest-capacity lines in the world) and other large-width, high-speed lines rationalise cost of production by 3-5% versus comparable new lines, and by roughly ₹15/kg compared with aged lines. - **R&D as a margin moat** - a centralised lab in Aurangabad with 30-plus scientists, six active patents and eleven more in the pipeline, and a first-of-its-kind food-packaging simulation lab called Packsmart let the company develop products such as TeploR, a heat-resistant BOPP film stable to 185°C that replaces BOPET in mono-material laminates; in bad markets, the margin gap over peers widens to 6-7%. - **Does not compete with its own customers** - the company stops at film manufacture and does no printing or conversion into finished packaging, so the converters and printers who buy its films are partners, not rivals. ## 2. Cosmo Speciality Chemicals: the high-margin, import-substitution bolt-on **An R&D-driven subsidiary making coating chemicals, masterbatches, and adhesives - products that the films business itself consumes, creating captive demand while outside sales grow at 25%-plus EBITDA margins.** - **Three verticals, each replacing imports** - the Coating Chemicals unit (7,000-tonne capacity) produces heat-seal and barrier coatings for foil and paperboard packaging; Masterbatches (10,000 tonnes) makes white and functional-additive masterbatches; and Adhesives (2,800 tonnes) produces water-based and solvent-free lamination adhesives for flexible packaging and folding boxes. - **Three-quarters of masterbatch output feeds the parent** - the first masterbatch line runs at 75% captive consumption for the films business, integrating the supply chain backward and insulating a chunk of volume from market fluctuations, while the remaining 25% is sold outside. - **Built step by step from 2020** - the business began with masterbatches (operational in FY21), added coating chemicals in FY22, and started commercial adhesive production in FY24, reaching ₹204 crores in sales by FY26 with a target of 7-8% of consolidated revenue within three to five years. - **Launched a consumer-facing product as a side bet** - during the pandemic it commercialised ‘Fabritizer’, an after-wash laundry sanitizer claiming 99.9% protection against viruses and bacteria on clothes, sold on Amazon India, demonstrating the R&D team’s ability to pivot into FMCG. ## 3. Cosmo Plastech: the rigid-packaging extension that sells straight to brands **An end-to-end rigid-packaging division making plastic sheets, thermoformed cups and trays, and injection-moulded IML containers - built to capture the ₹10,000-crore Indian rigid-packaging market growing at over 10% a year.** - **Direct-to-brand, cost-plus pricing** - roughly 56% of sales go directly to FMCG and food brands rather than through middlemen, and the cost-plus model delivers stable margins regardless of input-price moves. - **Food-contact certification unlocks the dairy and ready-to-eat aisle** - the division holds FSSC 22000 food-safety certification, which is mandatory for packaging that touches food directly, opening the door to yogurt, dairy, ice-cream, and processed-food customers. - **Two-phase build-out** - Phase 1 began commercial operations in October 2023 and Phase 2 in April 2024, with installed capacity of 18,000 tonnes; the business reached EBITDA breakeven in FY26 on revenue of ₹92 crore. ## 4. Cosmo Consumer: the window-film and paint-protection bet on Indian premiumisation **A high-margin consumer brand selling nano-ceramic window films and self-healing paint-protection films - one of only two domestic producers in a market where car-owners are just beginning to adopt PPF.** - **Nano-ceramic films that cut indoor temperatures by 2-5°C** - Cosmo Sunshield window films reject up to 95% of infrared rays and block over 99% of UV, targeting residential, commercial, automotive, and government buildings with a product that reduces cooling costs. - **Paint-protection films at 1-2% penetration** - the India PPF market is roughly ₹500 crore and growing at 30% a year, yet only 1-2% of Indian cars use PPF compared with about 15% in China, giving the business a long runway. - **Distribution built fast** - within its launch year (FY26), the business signed over 150 window-film distributors, 60-plus PPF distributors, and direct channel partners in more than ten cities, reaching 100-plus cities and hitting an annualised revenue run-rate of ₹38 crore. ## 5. Zigly: the digital-first petcare platform riding a 22%-growth market **A services-led, omni-channel petcare brand that combines 41 experience centres with an own e-commerce site and third-party marketplaces - and is steadily shifting its mix toward higher-margin vet services and private-label products.** - **Services, not just stuff** - veterinary services, grooming, and training contributed 61% of revenue in FY26, up from 51% the year before, lifting gross margins from 44% to 48% as the business tilts away from low-margin third-party product sales. - **Private labels doubled in a year** - own brands such as Zigly Lifestyle, Applod, and Fur Pro grew sales 103% year-on-year, with new launches spanning dry food, wet food, shampoo, and a winter collection across 5,000-plus SKUs. - **Bought two veterinary hospitals to deepen services** - in FY26 it acquired a two-decade-old small-animal clinic in Mumbai and a five-year-old animal healthcare practice in Bangalore via slump sales, adding diagnostic imaging and surgical capability to the platform. - **A community of 600,000-plus pet owners** - the platform served 71,000-plus customers in FY26 with a 35% repeat rate and has built a social-media following of over 313,000, while the Indian petcare market grows at 22-23% annually. # Group structure and partners **A New-Delhi-headquartered parent with three Indian plants, a network of overseas sales subsidiaries, and a 50:50 Korean distribution joint venture - plus minority stakes in renewable-energy SPVs to green the power supply.** - **Three Indian factories, no overseas manufacturing** - plants at Waluj and Shendra (both Aurangabad, Maharashtra) and Karjan (Vadodara, Gujarat) house all production; the former Korean thermal-lamination line was relocated to Shendra and commissioned in March 2025, and the Korean entity now operates purely as a sales and distribution outfit. - **International sales subsidiaries in five countries** - wholly-owned marketing and distribution arms operate in the USA, Japan, Singapore, the Netherlands, and Thailand, with the US entity moved directly under the parent in November 2025. - **Korean joint venture with Filmax Corporation** - in May 2026, a 50:50 JV called Filmax Cosmo Korea Limited was incorporated to distribute flexible-packaging products manufactured by both partners, with each side appointing two directors. - **Minority stakes in renewable-energy SPVs** - the group holds 26-31% stakes in three special-purpose vehicles that supply hybrid and solar power to the Aurangabad and Gujarat plants on a group-captive basis, part of a push to reach a two-thirds renewable energy mix. - **Petcare demerger in preparation** - a wholly-owned subsidiary, Zigly Pet Ventures Limited, was incorporated in June 2024 to receive the petcare business at a future date, signalling a planned separation of the vertical.

Documents — Cosmo First Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/x9385092oxuhxsteiaye7rp6.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/mm1tqsd6refrulvgdf77442l.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/yrzuq1iiuju7ki9chlkux1rh.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/vw5qwwx5epdn3emliwi2sauy.pdf
  • Q1 FY2026 Earnings Call Transcript (Jun 2025, PDF): https://www.stockscans.in/document/qdtj83h653yo1tha9yqi6qqk.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/n5vahel4i8ov2yvffzabrh9i.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/xyk1ffim8csrz9col33sm6ua.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/hipwb9mrjnoauuhsumy8yfz2.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/k313zyyq67j5qsmkvux573em.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/4wse6ns02pvlz7d4nzkna4n4.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/vhggzr6y05jfanmtxzkv757p.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/dv28rw0bt0wl1ks83kill8dt.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/anjyewhlei1imdfm7wrheih9.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/6i6nirsud3jjpk9dz142f20t.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/yz2cwigc9mut3sirfg38rzw6.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/jrjbbk98vw05y7gd39zxmx4i.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/z8r6kznf857pqqmcsdqc9u1z.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/ywrxsm6qaak4ghb19d8py5e3.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/ez9wiba2hzz7ubkmhwdxjlcp.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/a0rbw7hhh64auoejyd9bllob.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/nkp9nv6fvrojqn6s18twyl4g.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/w2vnq3ezhiymrj2p4oxbctnb.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/uj06vhzabd2bw2v5j38brpr9.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/clnixjhnn3vs1djjw4pr2vdz.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/rbs4t6xdcwlaus2bp4wxa655.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/kwa9gm2ozccttlv7u2s5vv91.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/2hzj46hjh3kpurf6008cg6cn.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/isd7ymbjbbw5la9rab6wsgm7.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/x9u6je4stl2ttdfsrrwtyog5.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/jr3plg89y5fr1ftpbacvxnkm.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/lup6t3v5xfvpemtaveq3ip3e.pdf

Concall Transcript Summaries — Cosmo First Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3ACOSMOFIRST/transcript-notes/202606/x9385092oxuhxsteiaye7rp6.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3ACOSMOFIRST/transcript-notes/202603/mm1tqsd6refrulvgdf77442l.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3ACOSMOFIRST/transcript-notes/202512/yrzuq1iiuju7ki9chlkux1rh.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3ACOSMOFIRST/transcript-notes/202509/vw5qwwx5epdn3emliwi2sauy.pdf
  • Q1 FY2026 Concall Transcript Summary (Jun 2025): https://www.stockscans.in/company/NSE%3ACOSMOFIRST/transcript-notes/202506/qdtj83h653yo1tha9yqi6qqk.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3ACOSMOFIRST/transcript-notes/202503/n5vahel4i8ov2yvffzabrh9i.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3ACOSMOFIRST/transcript-notes/202412/xyk1ffim8csrz9col33sm6ua.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3ACOSMOFIRST/transcript-notes/202409/hipwb9mrjnoauuhsumy8yfz2.pdf